NovaBridge Biosciences (NBP) — Cash Flow Quality Index
Latest as of December 2020:
-19.06x
NovaBridge Biosciences (NBP) has a Cash Flow Quality Index of -19.06x as of December 2020. Operating cash flow of $-232.84 Million is below net income of $12.22 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore NBP cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-19.06x
Operating CF / Net Income
Operating Cash Flow
$-232.84 Million
USD
Net Income
$12.22 Million
USD
Data as of
Dec 2020
Most recent filing
NovaBridge Biosciences Cash Flow Quality Index (2020–2020)
Historical Cash Flow Quality Index for NovaBridge Biosciences across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see NBP operating cash flow.
Annual Cash Flow Quality Index for NovaBridge Biosciences (2020–2020)
Year-by-year earnings quality comparison for NovaBridge Biosciences.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 0.92x | $433.56 Million | $470.92 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.